Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders
- PMID: 17822846
- DOI: 10.1016/j.neulet.2007.08.014
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders
Abstract
Evidence was recently presented from in vitro studies that 24S-hydroxycholesterol acts as a signalling molecule inducing apoE-mediated cholesterol efflux from astrocytoma cells, and that there is a direct effect of the oxysterol on apoE transcription, protein synthesis and secretion. Consistent with this mechanism, a significant correlation is demonstrated here between levels of apoE and 24S-hydroxycholesterol in cerebrospinal fluid from patients with Alzheimer's disease and patients with mild cognitive impairment. Such a correlation was not found in control patients. There was no correlation between levels of apoE and cholesterol in cerebrospinal fluid from controls. The results are consistent with a close coupling between release of 24S-hydroxycholesterol and apoE secretion under conditions with neuronal degeneration. The levels of apoE in cerebrospinal fluid were also correlated to the levels of Tau and the possibility is discussed that the level of apoE in cerebrospinal fluid may be used as a marker of neurodegeneration.
Similar articles
-
Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment.Biochem Soc Trans. 2010 Aug;38(4):1021-5. doi: 10.1042/BST0381021. Biochem Soc Trans. 2010. PMID: 20658997 Review.
-
24S-hydroxycholesterol: a marker of brain cholesterol metabolism.Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6. doi: 10.1055/s-2003-43053. Pharmacopsychiatry. 2003. PMID: 14574622
-
Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?Neurosci Lett. 2006 Apr 10-17;397(1-2):83-7. doi: 10.1016/j.neulet.2005.11.046. Epub 2006 Jan 6. Neurosci Lett. 2006. PMID: 16406316
-
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.Neurology. 2009 Mar 24;72(12):1056-61. doi: 10.1212/01.wnl.0000345014.48839.71. Neurology. 2009. PMID: 19307538
-
[Biomarkers in cerebrospinal fluid and blood in memory complaints].Lakartidningen. 2009 May 13-19;106(20):1386-9. Lakartidningen. 2009. PMID: 19585836 Review. Swedish. No abstract available.
Cited by
-
Brain cholesterol metabolism, oxysterols, and dementia.J Alzheimers Dis. 2013;33(4):891-911. doi: 10.3233/JAD-2012-121585. J Alzheimers Dis. 2013. PMID: 23076077 Free PMC article.
-
Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease.Exp Neurobiol. 2019 Oct 31;28(5):554-567. doi: 10.5607/en.2019.28.5.554. Exp Neurobiol. 2019. PMID: 31698548 Free PMC article. Review.
-
Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?J Cell Mol Med. 2008 Aug;12(4):1094-117. doi: 10.1111/j.1582-4934.2008.00313.x. Epub 2008 Mar 19. J Cell Mol Med. 2008. PMID: 18363842 Free PMC article. Review.
-
Apolipoprotein E and cholesterol in aging and disease in the brain.Future Lipidol. 2008 Oct;3(5):505-530. doi: 10.2217/17460875.3.5.505. Future Lipidol. 2008. PMID: 19649144 Free PMC article.
-
24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.Brain Res. 2010 Mar 10;1319:1-12. doi: 10.1016/j.brainres.2009.12.080. Epub 2010 Jan 4. Brain Res. 2010. PMID: 20053345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous